nodes	percent_of_prediction	percent_of_DWPC	metapath
Clozapine—CYP2A6—Nevirapine—acquired immunodeficiency syndrome	0.0444	0.055	CbGbCtD
Clozapine—CYP2A6—Zidovudine—acquired immunodeficiency syndrome	0.0292	0.0362	CbGbCtD
Clozapine—CYP2E1—Ritonavir—acquired immunodeficiency syndrome	0.0201	0.0249	CbGbCtD
Clozapine—CYP2C8—Amprenavir—acquired immunodeficiency syndrome	0.0198	0.0245	CbGbCtD
Clozapine—CYP2C8—Delavirdine—acquired immunodeficiency syndrome	0.0198	0.0245	CbGbCtD
Clozapine—CYP2C19—Efavirenz—acquired immunodeficiency syndrome	0.0195	0.0242	CbGbCtD
Clozapine—CYP2C19—Lopinavir—acquired immunodeficiency syndrome	0.0184	0.0228	CbGbCtD
Clozapine—CYP1A2—Efavirenz—acquired immunodeficiency syndrome	0.018	0.0223	CbGbCtD
Clozapine—CYP1A2—Lopinavir—acquired immunodeficiency syndrome	0.017	0.021	CbGbCtD
Clozapine—CYP1A2—Nevirapine—acquired immunodeficiency syndrome	0.017	0.021	CbGbCtD
Clozapine—CYP2C19—Amprenavir—acquired immunodeficiency syndrome	0.0166	0.0206	CbGbCtD
Clozapine—CYP2C19—Delavirdine—acquired immunodeficiency syndrome	0.0166	0.0206	CbGbCtD
Clozapine—CYP2C9—Efavirenz—acquired immunodeficiency syndrome	0.0163	0.0201	CbGbCtD
Clozapine—CYP1A2—Delavirdine—acquired immunodeficiency syndrome	0.0153	0.019	CbGbCtD
Clozapine—CYP2C9—Nevirapine—acquired immunodeficiency syndrome	0.0153	0.0189	CbGbCtD
Clozapine—CYP2C9—Lopinavir—acquired immunodeficiency syndrome	0.0153	0.0189	CbGbCtD
Clozapine—CYP2C8—Saquinavir—acquired immunodeficiency syndrome	0.015	0.0186	CbGbCtD
Clozapine—CYP2C8—Ritonavir—acquired immunodeficiency syndrome	0.015	0.0186	CbGbCtD
Clozapine—CYP2D6—Efavirenz—acquired immunodeficiency syndrome	0.0149	0.0184	CbGbCtD
Clozapine—ABCB1—Lopinavir—acquired immunodeficiency syndrome	0.0148	0.0184	CbGbCtD
Clozapine—CYP2C8—Zidovudine—acquired immunodeficiency syndrome	0.0144	0.0178	CbGbCtD
Clozapine—CYP2C19—Indinavir—acquired immunodeficiency syndrome	0.0143	0.0178	CbGbCtD
Clozapine—CYP2D6—Lopinavir—acquired immunodeficiency syndrome	0.014	0.0173	CbGbCtD
Clozapine—CYP2D6—Nevirapine—acquired immunodeficiency syndrome	0.014	0.0173	CbGbCtD
Clozapine—CYP2C19—Nelfinavir—acquired immunodeficiency syndrome	0.0139	0.0173	CbGbCtD
Clozapine—CYP2C9—Delavirdine—acquired immunodeficiency syndrome	0.0138	0.0171	CbGbCtD
Clozapine—CYP2C9—Amprenavir—acquired immunodeficiency syndrome	0.0138	0.0171	CbGbCtD
Clozapine—ABCB1—Amprenavir—acquired immunodeficiency syndrome	0.0134	0.0166	CbGbCtD
Clozapine—CYP1A2—Nelfinavir—acquired immunodeficiency syndrome	0.0129	0.0159	CbGbCtD
Clozapine—CYP2D6—Amprenavir—acquired immunodeficiency syndrome	0.0126	0.0156	CbGbCtD
Clozapine—CYP2D6—Delavirdine—acquired immunodeficiency syndrome	0.0126	0.0156	CbGbCtD
Clozapine—CYP2C19—Saquinavir—acquired immunodeficiency syndrome	0.0126	0.0156	CbGbCtD
Clozapine—CYP2C19—Ritonavir—acquired immunodeficiency syndrome	0.0126	0.0156	CbGbCtD
Clozapine—CYP2C19—Zidovudine—acquired immunodeficiency syndrome	0.0121	0.015	CbGbCtD
Clozapine—CYP2C9—Indinavir—acquired immunodeficiency syndrome	0.0119	0.0148	CbGbCtD
Clozapine—CYP1A2—Ritonavir—acquired immunodeficiency syndrome	0.0116	0.0144	CbGbCtD
Clozapine—CYP2C9—Nelfinavir—acquired immunodeficiency syndrome	0.0116	0.0143	CbGbCtD
Clozapine—ABCB1—Indinavir—acquired immunodeficiency syndrome	0.0116	0.0143	CbGbCtD
Clozapine—ABCB1—Nelfinavir—acquired immunodeficiency syndrome	0.0112	0.0139	CbGbCtD
Clozapine—CYP2D6—Indinavir—acquired immunodeficiency syndrome	0.0109	0.0135	CbGbCtD
Clozapine—CYP2D6—Nelfinavir—acquired immunodeficiency syndrome	0.0106	0.0131	CbGbCtD
Clozapine—CYP2C9—Ritonavir—acquired immunodeficiency syndrome	0.0105	0.013	CbGbCtD
Clozapine—CYP2C9—Saquinavir—acquired immunodeficiency syndrome	0.0105	0.013	CbGbCtD
Clozapine—ABCB1—Saquinavir—acquired immunodeficiency syndrome	0.0102	0.0126	CbGbCtD
Clozapine—ABCB1—Ritonavir—acquired immunodeficiency syndrome	0.0102	0.0126	CbGbCtD
Clozapine—CYP2C9—Zidovudine—acquired immunodeficiency syndrome	0.01	0.0124	CbGbCtD
Clozapine—ABCB1—Zidovudine—acquired immunodeficiency syndrome	0.00974	0.0121	CbGbCtD
Clozapine—CYP2D6—Saquinavir—acquired immunodeficiency syndrome	0.00958	0.0119	CbGbCtD
Clozapine—CYP2D6—Ritonavir—acquired immunodeficiency syndrome	0.00958	0.0119	CbGbCtD
Clozapine—CYP3A4—Efavirenz—acquired immunodeficiency syndrome	0.00945	0.0117	CbGbCtD
Clozapine—CYP3A4—Nevirapine—acquired immunodeficiency syndrome	0.00888	0.011	CbGbCtD
Clozapine—CYP3A4—Lopinavir—acquired immunodeficiency syndrome	0.00888	0.011	CbGbCtD
Clozapine—CYP3A4—Amprenavir—acquired immunodeficiency syndrome	0.00803	0.00995	CbGbCtD
Clozapine—CYP3A4—Delavirdine—acquired immunodeficiency syndrome	0.00803	0.00995	CbGbCtD
Clozapine—ABCB1—Lamivudine—acquired immunodeficiency syndrome	0.00754	0.00934	CbGbCtD
Clozapine—CYP3A4—Indinavir—acquired immunodeficiency syndrome	0.00694	0.00859	CbGbCtD
Clozapine—CYP3A4—Nelfinavir—acquired immunodeficiency syndrome	0.00673	0.00834	CbGbCtD
Clozapine—CYP3A4—Saquinavir—acquired immunodeficiency syndrome	0.00609	0.00754	CbGbCtD
Clozapine—CYP3A4—Ritonavir—acquired immunodeficiency syndrome	0.00609	0.00754	CbGbCtD
Clozapine—CYP3A4—Zidovudine—acquired immunodeficiency syndrome	0.00584	0.00723	CbGbCtD
Clozapine—H1F0—semen—acquired immunodeficiency syndrome	0.00423	0.0415	CbGeAlD
Clozapine—UGT1A4—blood plasma—acquired immunodeficiency syndrome	0.00298	0.0292	CbGeAlD
Clozapine—DRD1—nerve—acquired immunodeficiency syndrome	0.00201	0.0197	CbGeAlD
Clozapine—HTR3A—nerve—acquired immunodeficiency syndrome	0.00194	0.0191	CbGeAlD
Clozapine—HRH4—blood—acquired immunodeficiency syndrome	0.00163	0.016	CbGeAlD
Clozapine—HRH4—bone marrow—acquired immunodeficiency syndrome	0.00158	0.0155	CbGeAlD
Clozapine—CALY—spinal cord—acquired immunodeficiency syndrome	0.00139	0.0136	CbGeAlD
Clozapine—HTR7—nerve—acquired immunodeficiency syndrome	0.00126	0.0123	CbGeAlD
Clozapine—DRD2—nerve—acquired immunodeficiency syndrome	0.00119	0.0117	CbGeAlD
Clozapine—HRH3—digestive system—acquired immunodeficiency syndrome	0.00118	0.0116	CbGeAlD
Clozapine—CALY—nervous system—acquired immunodeficiency syndrome	0.00117	0.0115	CbGeAlD
Clozapine—UGT1A4—digestive system—acquired immunodeficiency syndrome	0.00115	0.0112	CbGeAlD
Clozapine—CALY—central nervous system—acquired immunodeficiency syndrome	0.00113	0.011	CbGeAlD
Clozapine—HRH3—blood—acquired immunodeficiency syndrome	0.00112	0.011	CbGeAlD
Clozapine—UGT1A4—blood—acquired immunodeficiency syndrome	0.00109	0.0107	CbGeAlD
Clozapine—HTR7—endothelium—acquired immunodeficiency syndrome	0.00107	0.0105	CbGeAlD
Clozapine—HTR1A—blood plasma—acquired immunodeficiency syndrome	0.000995	0.00976	CbGeAlD
Clozapine—HTR7—blood plasma—acquired immunodeficiency syndrome	0.000951	0.00932	CbGeAlD
Clozapine—CYP2C19—blood plasma—acquired immunodeficiency syndrome	0.000929	0.00911	CbGeAlD
Clozapine—HRH3—nervous system—acquired immunodeficiency syndrome	0.000912	0.00894	CbGeAlD
Clozapine—CALY—brain—acquired immunodeficiency syndrome	0.000895	0.00877	CbGeAlD
Clozapine—HRH3—central nervous system—acquired immunodeficiency syndrome	0.000878	0.00861	CbGeAlD
Clozapine—CALY—lymph node—acquired immunodeficiency syndrome	0.000865	0.00848	CbGeAlD
Clozapine—CHRM5—skin of body—acquired immunodeficiency syndrome	0.000859	0.00842	CbGeAlD
Clozapine—H1F0—retina—acquired immunodeficiency syndrome	0.000844	0.00828	CbGeAlD
Clozapine—CYP2C8—blood plasma—acquired immunodeficiency syndrome	0.000811	0.00795	CbGeAlD
Clozapine—HTR2A—nerve—acquired immunodeficiency syndrome	0.000784	0.00769	CbGeAlD
Clozapine—HTR1E—nervous system—acquired immunodeficiency syndrome	0.000776	0.0076	CbGeAlD
Clozapine—CYP1A2—blood plasma—acquired immunodeficiency syndrome	0.000759	0.00744	CbGeAlD
Clozapine—HTR1E—central nervous system—acquired immunodeficiency syndrome	0.000747	0.00732	CbGeAlD
Clozapine—H1F0—skin of body—acquired immunodeficiency syndrome	0.000741	0.00726	CbGeAlD
Clozapine—CYP2C9—blood plasma—acquired immunodeficiency syndrome	0.00072	0.00706	CbGeAlD
Clozapine—FMO3—vagina—acquired immunodeficiency syndrome	0.000714	0.007	CbGeAlD
Clozapine—ADRA2A—blood plasma—acquired immunodeficiency syndrome	0.000698	0.00684	CbGeAlD
Clozapine—HRH3—brain—acquired immunodeficiency syndrome	0.000697	0.00683	CbGeAlD
Clozapine—DRD4—brain—acquired immunodeficiency syndrome	0.000687	0.00674	CbGeAlD
Clozapine—CYP2E1—blood plasma—acquired immunodeficiency syndrome	0.000682	0.00669	CbGeAlD
Clozapine—CHRM4—nervous system—acquired immunodeficiency syndrome	0.00068	0.00667	CbGeAlD
Clozapine—FMO3—lung—acquired immunodeficiency syndrome	0.000675	0.00662	CbGeAlD
Clozapine—HTR2A—endothelium—acquired immunodeficiency syndrome	0.000668	0.00655	CbGeAlD
Clozapine—CHRM4—central nervous system—acquired immunodeficiency syndrome	0.000655	0.00642	CbGeAlD
Clozapine—DRD3—nervous system—acquired immunodeficiency syndrome	0.000632	0.0062	CbGeAlD
Clozapine—FMO3—nervous system—acquired immunodeficiency syndrome	0.000625	0.00613	CbGeAlD
Clozapine—DRD3—central nervous system—acquired immunodeficiency syndrome	0.000609	0.00597	CbGeAlD
Clozapine—HTR6—nervous system—acquired immunodeficiency syndrome	0.000609	0.00597	CbGeAlD
Clozapine—FMO3—central nervous system—acquired immunodeficiency syndrome	0.000602	0.0059	CbGeAlD
Clozapine—H1F0—lymphoid tissue—acquired immunodeficiency syndrome	0.0006	0.00588	CbGeAlD
Clozapine—HTR2A—blood plasma—acquired immunodeficiency syndrome	0.000593	0.00582	CbGeAlD
Clozapine—HTR1E—brain—acquired immunodeficiency syndrome	0.000593	0.00581	CbGeAlD
Clozapine—H1F0—digestive system—acquired immunodeficiency syndrome	0.000593	0.00581	CbGeAlD
Clozapine—HTR6—central nervous system—acquired immunodeficiency syndrome	0.000586	0.00574	CbGeAlD
Clozapine—HTR3A—digestive system—acquired immunodeficiency syndrome	0.000565	0.00554	CbGeAlD
Clozapine—H1F0—blood—acquired immunodeficiency syndrome	0.000565	0.00554	CbGeAlD
Clozapine—CYP3A4—blood plasma—acquired immunodeficiency syndrome	0.000549	0.00538	CbGeAlD
Clozapine—H1F0—bone marrow—acquired immunodeficiency syndrome	0.000546	0.00536	CbGeAlD
Clozapine—H1F0—spinal cord—acquired immunodeficiency syndrome	0.000544	0.00533	CbGeAlD
Clozapine—CYP2D6—blood plasma—acquired immunodeficiency syndrome	0.00054	0.0053	CbGeAlD
Clozapine—HTR3A—blood—acquired immunodeficiency syndrome	0.000539	0.00528	CbGeAlD
Clozapine—CHRM5—nervous system—acquired immunodeficiency syndrome	0.000532	0.00521	CbGeAlD
Clozapine—H1F0—vagina—acquired immunodeficiency syndrome	0.000523	0.00513	CbGeAlD
Clozapine—CHRM4—brain—acquired immunodeficiency syndrome	0.00052	0.0051	CbGeAlD
Clozapine—CHRM5—central nervous system—acquired immunodeficiency syndrome	0.000512	0.00502	CbGeAlD
Clozapine—CYP1B1—skin of body—acquired immunodeficiency syndrome	0.000509	0.00499	CbGeAlD
Clozapine—H1F0—lung—acquired immunodeficiency syndrome	0.000495	0.00485	CbGeAlD
Clozapine—DRD2—retina—acquired immunodeficiency syndrome	0.000492	0.00483	CbGeAlD
Clozapine—CYP2A6—vagina—acquired immunodeficiency syndrome	0.00049	0.00481	CbGeAlD
Clozapine—ADRA1B—nervous system—acquired immunodeficiency syndrome	0.000486	0.00476	CbGeAlD
Clozapine—DRD3—brain—acquired immunodeficiency syndrome	0.000483	0.00474	CbGeAlD
Clozapine—FMO3—brain—acquired immunodeficiency syndrome	0.000478	0.00468	CbGeAlD
Clozapine—HTR3A—lung—acquired immunodeficiency syndrome	0.000472	0.00463	CbGeAlD
Clozapine—ADRA1B—central nervous system—acquired immunodeficiency syndrome	0.000468	0.00458	CbGeAlD
Clozapine—HTR6—brain—acquired immunodeficiency syndrome	0.000465	0.00456	CbGeAlD
Clozapine—CYP2A6—lung—acquired immunodeficiency syndrome	0.000464	0.00455	CbGeAlD
Clozapine—FMO3—lymph node—acquired immunodeficiency syndrome	0.000462	0.00453	CbGeAlD
Clozapine—H1F0—nervous system—acquired immunodeficiency syndrome	0.000458	0.00449	CbGeAlD
Clozapine—DRD1—nervous system—acquired immunodeficiency syndrome	0.000453	0.00444	CbGeAlD
Clozapine—H1F0—central nervous system—acquired immunodeficiency syndrome	0.000441	0.00433	CbGeAlD
Clozapine—HTR3A—nervous system—acquired immunodeficiency syndrome	0.000437	0.00429	CbGeAlD
Clozapine—DRD1—central nervous system—acquired immunodeficiency syndrome	0.000436	0.00427	CbGeAlD
Clozapine—HTR1B—spinal cord—acquired immunodeficiency syndrome	0.000435	0.00427	CbGeAlD
Clozapine—HTR3A—central nervous system—acquired immunodeficiency syndrome	0.000421	0.00413	CbGeAlD
Clozapine—HTR2C—spinal cord—acquired immunodeficiency syndrome	0.000417	0.00409	CbGeAlD
Clozapine—CYP1B1—lymphoid tissue—acquired immunodeficiency syndrome	0.000412	0.00404	CbGeAlD
Clozapine—CYP1B1—digestive system—acquired immunodeficiency syndrome	0.000407	0.00399	CbGeAlD
Clozapine—CHRM5—brain—acquired immunodeficiency syndrome	0.000406	0.00398	CbGeAlD
Clozapine—ABCB1—blood plasma—acquired immunodeficiency syndrome	0.000389	0.00381	CbGeAlD
Clozapine—CYP1B1—blood—acquired immunodeficiency syndrome	0.000388	0.0038	CbGeAlD
Clozapine—CHRM3—digestive system—acquired immunodeficiency syndrome	0.000384	0.00377	CbGeAlD
Clozapine—ADRA1B—brain—acquired immunodeficiency syndrome	0.000371	0.00364	CbGeAlD
Clozapine—HTR1B—nervous system—acquired immunodeficiency syndrome	0.000367	0.0036	CbGeAlD
Clozapine—HTR7—digestive system—acquired immunodeficiency syndrome	0.000366	0.00359	CbGeAlD
Clozapine—CHRM2—nervous system—acquired immunodeficiency syndrome	0.000365	0.00358	CbGeAlD
Clozapine—CYP1A1—skin of body—acquired immunodeficiency syndrome	0.00036	0.00353	CbGeAlD
Clozapine—CHRM1—lung—acquired immunodeficiency syndrome	0.000359	0.00352	CbGeAlD
Clozapine—CYP2C19—digestive system—acquired immunodeficiency syndrome	0.000357	0.0035	CbGeAlD
Clozapine—ADRA1A—lymphoid tissue—acquired immunodeficiency syndrome	0.000357	0.0035	CbGeAlD
Clozapine—HTR1D—nervous system—acquired immunodeficiency syndrome	0.000355	0.00348	CbGeAlD
Clozapine—HTR1B—central nervous system—acquired immunodeficiency syndrome	0.000353	0.00346	CbGeAlD
Clozapine—HTR2C—nervous system—acquired immunodeficiency syndrome	0.000352	0.00345	CbGeAlD
Clozapine—HTR1A—spinal cord—acquired immunodeficiency syndrome	0.000351	0.00344	CbGeAlD
Clozapine—CHRM2—central nervous system—acquired immunodeficiency syndrome	0.000351	0.00344	CbGeAlD
Clozapine—H1F0—brain—acquired immunodeficiency syndrome	0.00035	0.00344	CbGeAlD
Clozapine—HTR7—blood—acquired immunodeficiency syndrome	0.000348	0.00342	CbGeAlD
Clozapine—DRD1—brain—acquired immunodeficiency syndrome	0.000346	0.00339	CbGeAlD
Clozapine—HTR1D—central nervous system—acquired immunodeficiency syndrome	0.000342	0.00335	CbGeAlD
Clozapine—CYP2C19—blood—acquired immunodeficiency syndrome	0.00034	0.00334	CbGeAlD
Clozapine—CYP1B1—lung—acquired immunodeficiency syndrome	0.00034	0.00333	CbGeAlD
Clozapine—H1F0—lymph node—acquired immunodeficiency syndrome	0.000339	0.00332	CbGeAlD
Clozapine—HTR2C—central nervous system—acquired immunodeficiency syndrome	0.000339	0.00332	CbGeAlD
Clozapine—ADRA1A—blood—acquired immunodeficiency syndrome	0.000336	0.0033	CbGeAlD
Clozapine—HTR7—spinal cord—acquired immunodeficiency syndrome	0.000336	0.00329	CbGeAlD
Clozapine—HTR3A—brain—acquired immunodeficiency syndrome	0.000334	0.00328	CbGeAlD
Clozapine—CHRM1—nervous system—acquired immunodeficiency syndrome	0.000332	0.00326	CbGeAlD
Clozapine—CYP2A6—brain—acquired immunodeficiency syndrome	0.000328	0.00322	CbGeAlD
Clozapine—HTR2A—retina—acquired immunodeficiency syndrome	0.000325	0.00318	CbGeAlD
Clozapine—ADRA2C—blood—acquired immunodeficiency syndrome	0.00032	0.00314	CbGeAlD
Clozapine—CHRM1—central nervous system—acquired immunodeficiency syndrome	0.00032	0.00313	CbGeAlD
Clozapine—CYP2C19—vagina—acquired immunodeficiency syndrome	0.000315	0.00309	CbGeAlD
Clozapine—CYP1B1—nervous system—acquired immunodeficiency syndrome	0.000315	0.00309	CbGeAlD
Clozapine—ADRA2C—spinal cord—acquired immunodeficiency syndrome	0.000309	0.00303	CbGeAlD
Clozapine—HTR7—lung—acquired immunodeficiency syndrome	0.000305	0.00299	CbGeAlD
Clozapine—CYP1B1—central nervous system—acquired immunodeficiency syndrome	0.000303	0.00297	CbGeAlD
Clozapine—CHRM3—nervous system—acquired immunodeficiency syndrome	0.000297	0.00291	CbGeAlD
Clozapine—CYP2C8—blood—acquired immunodeficiency syndrome	0.000297	0.00291	CbGeAlD
Clozapine—ADRA2C—vagina—acquired immunodeficiency syndrome	0.000297	0.00291	CbGeAlD
Clozapine—HTR1A—nervous system—acquired immunodeficiency syndrome	0.000296	0.0029	CbGeAlD
Clozapine—CYP1A2—digestive system—acquired immunodeficiency syndrome	0.000292	0.00286	CbGeAlD
Clozapine—DRD2—lung—acquired immunodeficiency syndrome	0.000289	0.00283	CbGeAlD
Clozapine—CYP1A1—digestive system—acquired immunodeficiency syndrome	0.000288	0.00282	CbGeAlD
Clozapine—CHRM3—central nervous system—acquired immunodeficiency syndrome	0.000286	0.00281	CbGeAlD
Clozapine—HTR1A—central nervous system—acquired immunodeficiency syndrome	0.000285	0.00279	CbGeAlD
Clozapine—HTR7—nervous system—acquired immunodeficiency syndrome	0.000283	0.00277	CbGeAlD
Clozapine—ADRA2C—lung—acquired immunodeficiency syndrome	0.000281	0.00275	CbGeAlD
Clozapine—HTR1B—brain—acquired immunodeficiency syndrome	0.00028	0.00275	CbGeAlD
Clozapine—CHRM2—brain—acquired immunodeficiency syndrome	0.000279	0.00273	CbGeAlD
Clozapine—CYP1A2—blood—acquired immunodeficiency syndrome	0.000278	0.00272	CbGeAlD
Clozapine—CYP2C9—digestive system—acquired immunodeficiency syndrome	0.000277	0.00271	CbGeAlD
Clozapine—CYP2C8—vagina—acquired immunodeficiency syndrome	0.000275	0.0027	CbGeAlD
Clozapine—CYP1A1—blood—acquired immunodeficiency syndrome	0.000274	0.00269	CbGeAlD
Clozapine—HRH1—digestive system—acquired immunodeficiency syndrome	0.000273	0.00268	CbGeAlD
Clozapine—ADRA1A—nervous system—acquired immunodeficiency syndrome	0.000273	0.00267	CbGeAlD
Clozapine—HTR7—central nervous system—acquired immunodeficiency syndrome	0.000272	0.00267	CbGeAlD
Clozapine—HTR1D—brain—acquired immunodeficiency syndrome	0.000271	0.00266	CbGeAlD
Clozapine—HTR2C—brain—acquired immunodeficiency syndrome	0.000269	0.00264	CbGeAlD
Clozapine—DRD2—nervous system—acquired immunodeficiency syndrome	0.000267	0.00262	CbGeAlD
Clozapine—CYP2E1—lymphoid tissue—acquired immunodeficiency syndrome	0.000266	0.0026	CbGeAlD
Clozapine—CYP2C9—blood—acquired immunodeficiency syndrome	0.000264	0.00259	CbGeAlD
Clozapine—ADRA1A—central nervous system—acquired immunodeficiency syndrome	0.000263	0.00258	CbGeAlD
Clozapine—CYP2E1—digestive system—acquired immunodeficiency syndrome	0.000262	0.00257	CbGeAlD
Clozapine—ADRA2C—nervous system—acquired immunodeficiency syndrome	0.00026	0.00255	CbGeAlD
Clozapine—DRD2—central nervous system—acquired immunodeficiency syndrome	0.000258	0.00252	CbGeAlD
Clozapine—ADRA2A—blood—acquired immunodeficiency syndrome	0.000256	0.00251	CbGeAlD
Clozapine—CYP1A1—vagina—acquired immunodeficiency syndrome	0.000254	0.00249	CbGeAlD
Clozapine—CHRM1—brain—acquired immunodeficiency syndrome	0.000254	0.00249	CbGeAlD
Clozapine—ADRA2C—central nervous system—acquired immunodeficiency syndrome	0.00025	0.00245	CbGeAlD
Clozapine—CYP2E1—blood—acquired immunodeficiency syndrome	0.00025	0.00245	CbGeAlD
Clozapine—ADRA2A—spinal cord—acquired immunodeficiency syndrome	0.000246	0.00241	CbGeAlD
Clozapine—CYP1A2—lung—acquired immunodeficiency syndrome	0.000244	0.00239	CbGeAlD
Clozapine—HRH1—vagina—acquired immunodeficiency syndrome	0.000241	0.00236	CbGeAlD
Clozapine—CYP2E1—spinal cord—acquired immunodeficiency syndrome	0.000241	0.00236	CbGeAlD
Clozapine—CYP1B1—brain—acquired immunodeficiency syndrome	0.000241	0.00236	CbGeAlD
Clozapine—CYP1A1—lung—acquired immunodeficiency syndrome	0.00024	0.00236	CbGeAlD
Clozapine—ADRA2A—vagina—acquired immunodeficiency syndrome	0.000237	0.00232	CbGeAlD
Clozapine—CYP1B1—lymph node—acquired immunodeficiency syndrome	0.000233	0.00228	CbGeAlD
Clozapine—HTR2A—digestive system—acquired immunodeficiency syndrome	0.000228	0.00224	CbGeAlD
Clozapine—HRH1—lung—acquired immunodeficiency syndrome	0.000228	0.00224	CbGeAlD
Clozapine—CHRM3—brain—acquired immunodeficiency syndrome	0.000227	0.00223	CbGeAlD
Clozapine—HTR1A—brain—acquired immunodeficiency syndrome	0.000226	0.00222	CbGeAlD
Clozapine—ADRA2A—lung—acquired immunodeficiency syndrome	0.000224	0.0022	CbGeAlD
Clozapine—CYP1A1—nervous system—acquired immunodeficiency syndrome	0.000223	0.00218	CbGeAlD
Clozapine—CYP2E1—lung—acquired immunodeficiency syndrome	0.000219	0.00215	CbGeAlD
Clozapine—HTR2A—blood—acquired immunodeficiency syndrome	0.000217	0.00213	CbGeAlD
Clozapine—HTR7—brain—acquired immunodeficiency syndrome	0.000216	0.00212	CbGeAlD
Clozapine—CYP1A1—central nervous system—acquired immunodeficiency syndrome	0.000214	0.0021	CbGeAlD
Clozapine—ABCB1—retina—acquired immunodeficiency syndrome	0.000213	0.00209	CbGeAlD
Clozapine—HRH1—nervous system—acquired immunodeficiency syndrome	0.000211	0.00207	CbGeAlD
Clozapine—CYP3A4—digestive system—acquired immunodeficiency syndrome	0.000211	0.00207	CbGeAlD
Clozapine—HTR2A—spinal cord—acquired immunodeficiency syndrome	0.000209	0.00205	CbGeAlD
Clozapine—ADRA1A—brain—acquired immunodeficiency syndrome	0.000209	0.00204	CbGeAlD
Clozapine—CYP2D6—digestive system—acquired immunodeficiency syndrome	0.000208	0.00204	CbGeAlD
Clozapine—ADRA2A—nervous system—acquired immunodeficiency syndrome	0.000207	0.00203	CbGeAlD
Clozapine—DRD2—brain—acquired immunodeficiency syndrome	0.000204	0.002	CbGeAlD
Clozapine—HRH1—central nervous system—acquired immunodeficiency syndrome	0.000203	0.00199	CbGeAlD
Clozapine—CYP2E1—nervous system—acquired immunodeficiency syndrome	0.000203	0.00199	CbGeAlD
Clozapine—HTR2A—vagina—acquired immunodeficiency syndrome	0.000201	0.00197	CbGeAlD
Clozapine—CYP3A4—blood—acquired immunodeficiency syndrome	0.000201	0.00197	CbGeAlD
Clozapine—ADRA2A—central nervous system—acquired immunodeficiency syndrome	0.0002	0.00196	CbGeAlD
Clozapine—ADRA2C—brain—acquired immunodeficiency syndrome	0.000199	0.00195	CbGeAlD
Clozapine—CYP2D6—blood—acquired immunodeficiency syndrome	0.000198	0.00194	CbGeAlD
Clozapine—CYP2E1—central nervous system—acquired immunodeficiency syndrome	0.000195	0.00192	CbGeAlD
Clozapine—ADRA2C—lymph node—acquired immunodeficiency syndrome	0.000192	0.00188	CbGeAlD
Clozapine—HTR2A—lung—acquired immunodeficiency syndrome	0.00019	0.00187	CbGeAlD
Clozapine—CYP2C8—brain—acquired immunodeficiency syndrome	0.000184	0.00181	CbGeAlD
Clozapine—HTR2A—nervous system—acquired immunodeficiency syndrome	0.000176	0.00173	CbGeAlD
Clozapine—CYP1A1—brain—acquired immunodeficiency syndrome	0.00017	0.00167	CbGeAlD
Clozapine—HTR2A—central nervous system—acquired immunodeficiency syndrome	0.00017	0.00166	CbGeAlD
Clozapine—CYP1A1—lymph node—acquired immunodeficiency syndrome	0.000164	0.00161	CbGeAlD
Clozapine—CYP3A4—nervous system—acquired immunodeficiency syndrome	0.000163	0.0016	CbGeAlD
Clozapine—HRH1—brain—acquired immunodeficiency syndrome	0.000161	0.00158	CbGeAlD
Clozapine—CYP2D6—nervous system—acquired immunodeficiency syndrome	0.000161	0.00158	CbGeAlD
Clozapine—ADRA2A—brain—acquired immunodeficiency syndrome	0.000159	0.00155	CbGeAlD
Clozapine—CYP3A4—central nervous system—acquired immunodeficiency syndrome	0.000157	0.00154	CbGeAlD
Clozapine—HRH1—lymph node—acquired immunodeficiency syndrome	0.000156	0.00153	CbGeAlD
Clozapine—CYP2E1—brain—acquired immunodeficiency syndrome	0.000155	0.00152	CbGeAlD
Clozapine—CYP2D6—central nervous system—acquired immunodeficiency syndrome	0.000155	0.00152	CbGeAlD
Clozapine—ADRA2A—lymph node—acquired immunodeficiency syndrome	0.000153	0.0015	CbGeAlD
Clozapine—ABCB1—lymphoid tissue—acquired immunodeficiency syndrome	0.000151	0.00148	CbGeAlD
Clozapine—ABCB1—digestive system—acquired immunodeficiency syndrome	0.000149	0.00147	CbGeAlD
Clozapine—ABCB1—blood—acquired immunodeficiency syndrome	0.000142	0.0014	CbGeAlD
Clozapine—ABCB1—bone marrow—acquired immunodeficiency syndrome	0.000138	0.00135	CbGeAlD
Clozapine—ABCB1—spinal cord—acquired immunodeficiency syndrome	0.000137	0.00134	CbGeAlD
Clozapine—HTR2A—brain—acquired immunodeficiency syndrome	0.000135	0.00132	CbGeAlD
Clozapine—ABCB1—vagina—acquired immunodeficiency syndrome	0.000132	0.00129	CbGeAlD
Clozapine—ABCB1—lung—acquired immunodeficiency syndrome	0.000125	0.00122	CbGeAlD
Clozapine—CYP2D6—brain—acquired immunodeficiency syndrome	0.000123	0.0012	CbGeAlD
Clozapine—ABCB1—nervous system—acquired immunodeficiency syndrome	0.000116	0.00113	CbGeAlD
Clozapine—ABCB1—central nervous system—acquired immunodeficiency syndrome	0.000111	0.00109	CbGeAlD
Clozapine—ABCB1—brain—acquired immunodeficiency syndrome	8.84e-05	0.000866	CbGeAlD
Clozapine—ABCB1—lymph node—acquired immunodeficiency syndrome	8.54e-05	0.000837	CbGeAlD
Clozapine—Clonazepam—ALB—acquired immunodeficiency syndrome	4.32e-05	0.298	CrCbGaD
Clozapine—Olanzapine—ALB—acquired immunodeficiency syndrome	4.19e-05	0.288	CrCbGaD
Clozapine—Thiothixene—ALB—acquired immunodeficiency syndrome	3.79e-05	0.261	CrCbGaD
Clozapine—Diazepam—ALB—acquired immunodeficiency syndrome	2.21e-05	0.152	CrCbGaD
Clozapine—HTR6—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	1.48e-05	0.000164	CbGpPWpGaD
Clozapine—ADRA2A—Signaling by GPCR—CCL5—acquired immunodeficiency syndrome	1.48e-05	0.000164	CbGpPWpGaD
Clozapine—HTR7—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	1.48e-05	0.000164	CbGpPWpGaD
Clozapine—CHRM1—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	1.48e-05	0.000164	CbGpPWpGaD
Clozapine—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—acquired immunodeficiency syndrome	1.48e-05	0.000163	CbGpPWpGaD
Clozapine—CHRM3—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	1.48e-05	0.000163	CbGpPWpGaD
Clozapine—HTR1D—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	1.47e-05	0.000163	CbGpPWpGaD
Clozapine—ADRA2A—GPCR downstream signaling—CCR5—acquired immunodeficiency syndrome	1.47e-05	0.000163	CbGpPWpGaD
Clozapine—HTR2A—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	1.47e-05	0.000162	CbGpPWpGaD
Clozapine—HRH1—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	1.47e-05	0.000162	CbGpPWpGaD
Clozapine—HTR1A—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	1.47e-05	0.000162	CbGpPWpGaD
Clozapine—HTR1A—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	1.47e-05	0.000162	CbGpPWpGaD
Clozapine—HTR1B—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	1.46e-05	0.000162	CbGpPWpGaD
Clozapine—CHRM2—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	1.46e-05	0.000162	CbGpPWpGaD
Clozapine—HTR6—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	1.46e-05	0.000162	CbGpPWpGaD
Clozapine—ADRA2A—Signaling by GPCR—CSF2—acquired immunodeficiency syndrome	1.46e-05	0.000162	CbGpPWpGaD
Clozapine—CHRM1—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	1.46e-05	0.000162	CbGpPWpGaD
Clozapine—HTR7—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	1.46e-05	0.000161	CbGpPWpGaD
Clozapine—ADRA1A—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	1.46e-05	0.000161	CbGpPWpGaD
Clozapine—HTR2C—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	1.46e-05	0.000161	CbGpPWpGaD
Clozapine—HTR2C—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	1.46e-05	0.000161	CbGpPWpGaD
Clozapine—CHRM3—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	1.46e-05	0.000161	CbGpPWpGaD
Clozapine—HTR1D—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	1.45e-05	0.00016	CbGpPWpGaD
Clozapine—CHRM2—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	1.44e-05	0.000159	CbGpPWpGaD
Clozapine—HTR1B—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	1.44e-05	0.000159	CbGpPWpGaD
Clozapine—DRD4—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	1.44e-05	0.000159	CbGpPWpGaD
Clozapine—ADRA1A—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	1.44e-05	0.000159	CbGpPWpGaD
Clozapine—CHRM4—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	1.42e-05	0.000157	CbGpPWpGaD
Clozapine—HTR1B—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	1.42e-05	0.000157	CbGpPWpGaD
Clozapine—DRD4—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	1.42e-05	0.000157	CbGpPWpGaD
Clozapine—ADRA2C—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	1.42e-05	0.000157	CbGpPWpGaD
Clozapine—ADRA2C—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	1.42e-05	0.000157	CbGpPWpGaD
Clozapine—CHRM4—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	1.4e-05	0.000155	CbGpPWpGaD
Clozapine—DRD4—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	1.4e-05	0.000155	CbGpPWpGaD
Clozapine—CYP3A4—Metabolism—AGPS—acquired immunodeficiency syndrome	1.4e-05	0.000155	CbGpPWpGaD
Clozapine—ADRA1B—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	1.4e-05	0.000154	CbGpPWpGaD
Clozapine—ADRA1B—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	1.4e-05	0.000154	CbGpPWpGaD
Clozapine—CHRM4—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	1.38e-05	0.000152	CbGpPWpGaD
Clozapine—DRD2—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	1.37e-05	0.000151	CbGpPWpGaD
Clozapine—CHRM5—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	1.36e-05	0.00015	CbGpPWpGaD
Clozapine—HTR6—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	1.36e-05	0.00015	CbGpPWpGaD
Clozapine—HTR7—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	1.36e-05	0.00015	CbGpPWpGaD
Clozapine—ADRA2A—Signaling Pathways—CCL3—acquired immunodeficiency syndrome	1.36e-05	0.00015	CbGpPWpGaD
Clozapine—HTR2A—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	1.35e-05	0.000149	CbGpPWpGaD
Clozapine—HTR1D—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	1.35e-05	0.000149	CbGpPWpGaD
Clozapine—ADRA2A—Hemostasis—IL2—acquired immunodeficiency syndrome	1.35e-05	0.000149	CbGpPWpGaD
Clozapine—HRH1—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	1.34e-05	0.000149	CbGpPWpGaD
Clozapine—CHRM5—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	1.34e-05	0.000148	CbGpPWpGaD
Clozapine—CHRM1—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	1.34e-05	0.000148	CbGpPWpGaD
Clozapine—ADRA2A—Signaling by GPCR—CCR5—acquired immunodeficiency syndrome	1.34e-05	0.000148	CbGpPWpGaD
Clozapine—CHRM3—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	1.34e-05	0.000148	CbGpPWpGaD
Clozapine—HTR6—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	1.33e-05	0.000147	CbGpPWpGaD
Clozapine—HTR7—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	1.33e-05	0.000147	CbGpPWpGaD
Clozapine—CHRM2—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	1.32e-05	0.000146	CbGpPWpGaD
Clozapine—CHRM5—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	1.32e-05	0.000146	CbGpPWpGaD
Clozapine—ADRA1A—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	1.32e-05	0.000146	CbGpPWpGaD
Clozapine—HTR1B—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	1.32e-05	0.000146	CbGpPWpGaD
Clozapine—HRH4—Signaling Pathways—IL2—acquired immunodeficiency syndrome	1.32e-05	0.000146	CbGpPWpGaD
Clozapine—HTR1D—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	1.32e-05	0.000146	CbGpPWpGaD
Clozapine—HRH4—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	1.31e-05	0.000145	CbGpPWpGaD
Clozapine—CYP1A1—Metabolism of lipids and lipoproteins—ALB—acquired immunodeficiency syndrome	1.31e-05	0.000145	CbGpPWpGaD
Clozapine—DRD4—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	1.3e-05	0.000143	CbGpPWpGaD
Clozapine—DRD1—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	1.3e-05	0.000143	CbGpPWpGaD
Clozapine—HTR1B—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	1.29e-05	0.000143	CbGpPWpGaD
Clozapine—DRD2—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	1.29e-05	0.000142	CbGpPWpGaD
Clozapine—DRD2—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	1.29e-05	0.000142	CbGpPWpGaD
Clozapine—CHRM4—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	1.28e-05	0.000142	CbGpPWpGaD
Clozapine—DRD3—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	1.28e-05	0.000141	CbGpPWpGaD
Clozapine—DRD1—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	1.28e-05	0.000141	CbGpPWpGaD
Clozapine—DRD4—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	1.27e-05	0.00014	CbGpPWpGaD
Clozapine—HTR2A—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	1.27e-05	0.00014	CbGpPWpGaD
Clozapine—HTR2A—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	1.27e-05	0.00014	CbGpPWpGaD
Clozapine—HRH1—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	1.26e-05	0.00014	CbGpPWpGaD
Clozapine—HRH1—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	1.26e-05	0.00014	CbGpPWpGaD
Clozapine—DRD3—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	1.26e-05	0.000139	CbGpPWpGaD
Clozapine—CHRM1—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	1.26e-05	0.000139	CbGpPWpGaD
Clozapine—CHRM1—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	1.26e-05	0.000139	CbGpPWpGaD
Clozapine—DRD1—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	1.26e-05	0.000139	CbGpPWpGaD
Clozapine—CHRM3—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	1.26e-05	0.000139	CbGpPWpGaD
Clozapine—CHRM3—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	1.26e-05	0.000139	CbGpPWpGaD
Clozapine—CHRM4—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	1.25e-05	0.000138	CbGpPWpGaD
Clozapine—CHRM2—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	1.24e-05	0.000137	CbGpPWpGaD
Clozapine—CHRM2—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	1.24e-05	0.000137	CbGpPWpGaD
Clozapine—DRD3—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	1.24e-05	0.000137	CbGpPWpGaD
Clozapine—ADRA1A—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	1.24e-05	0.000137	CbGpPWpGaD
Clozapine—ADRA1A—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	1.24e-05	0.000137	CbGpPWpGaD
Clozapine—CHRM5—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	1.23e-05	0.000136	CbGpPWpGaD
Clozapine—ADRA2A—Signaling Pathways—CCR2—acquired immunodeficiency syndrome	1.23e-05	0.000135	CbGpPWpGaD
Clozapine—CYP2C8—Metabolism of lipids and lipoproteins—ALB—acquired immunodeficiency syndrome	1.2e-05	0.000133	CbGpPWpGaD
Clozapine—CHRM5—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	1.2e-05	0.000133	CbGpPWpGaD
Clozapine—DRD1—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	1.17e-05	0.000129	CbGpPWpGaD
Clozapine—ADRA2B—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	1.16e-05	0.000128	CbGpPWpGaD
Clozapine—DRD3—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	1.15e-05	0.000127	CbGpPWpGaD
Clozapine—ADRA2A—Signaling Pathways—CXCR4—acquired immunodeficiency syndrome	1.15e-05	0.000127	CbGpPWpGaD
Clozapine—ADRA2A—Signaling Pathways—CXCL12—acquired immunodeficiency syndrome	1.15e-05	0.000127	CbGpPWpGaD
Clozapine—HTR1E—Signaling Pathways—IL2—acquired immunodeficiency syndrome	1.15e-05	0.000127	CbGpPWpGaD
Clozapine—DRD1—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	1.14e-05	0.000126	CbGpPWpGaD
Clozapine—HTR1E—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	1.14e-05	0.000126	CbGpPWpGaD
Clozapine—ADRA2B—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	1.14e-05	0.000126	CbGpPWpGaD
Clozapine—DRD3—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	1.13e-05	0.000125	CbGpPWpGaD
Clozapine—ADRA2B—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	1.12e-05	0.000124	CbGpPWpGaD
Clozapine—HTR1A—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	1.12e-05	0.000123	CbGpPWpGaD
Clozapine—HTR2C—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	1.11e-05	0.000123	CbGpPWpGaD
Clozapine—HTR1A—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	1.1e-05	0.000121	CbGpPWpGaD
Clozapine—HTR2C—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	1.09e-05	0.000121	CbGpPWpGaD
Clozapine—HTR1A—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	1.08e-05	0.00012	CbGpPWpGaD
Clozapine—ADRA2C—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	1.08e-05	0.000119	CbGpPWpGaD
Clozapine—HTR2C—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	1.08e-05	0.000119	CbGpPWpGaD
Clozapine—CYP2C19—Metabolism of lipids and lipoproteins—ALB—acquired immunodeficiency syndrome	1.07e-05	0.000118	CbGpPWpGaD
Clozapine—ADRA2C—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	1.06e-05	0.000117	CbGpPWpGaD
Clozapine—ADRA1B—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	1.06e-05	0.000117	CbGpPWpGaD
Clozapine—ADRA2C—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	1.05e-05	0.000116	CbGpPWpGaD
Clozapine—ADRA1B—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	1.05e-05	0.000116	CbGpPWpGaD
Clozapine—ADRA2B—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	1.04e-05	0.000115	CbGpPWpGaD
Clozapine—ADRA1B—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	1.03e-05	0.000114	CbGpPWpGaD
Clozapine—ADRA2B—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	1.02e-05	0.000113	CbGpPWpGaD
Clozapine—HTR1A—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	1e-05	0.000111	CbGpPWpGaD
Clozapine—HTR2C—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	1e-05	0.00011	CbGpPWpGaD
Clozapine—ABCB1—Transmembrane transport of small molecules—ALB—acquired immunodeficiency syndrome	9.94e-06	0.00011	CbGpPWpGaD
Clozapine—HTR1A—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	9.83e-06	0.000109	CbGpPWpGaD
Clozapine—DRD2—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	9.79e-06	0.000108	CbGpPWpGaD
Clozapine—HTR2C—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	9.78e-06	0.000108	CbGpPWpGaD
Clozapine—CYP2C9—Metabolism of lipids and lipoproteins—ALB—acquired immunodeficiency syndrome	9.76e-06	0.000108	CbGpPWpGaD
Clozapine—ADRA2C—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	9.72e-06	0.000107	CbGpPWpGaD
Clozapine—DRD2—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	9.65e-06	0.000107	CbGpPWpGaD
Clozapine—HTR2A—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	9.64e-06	0.000106	CbGpPWpGaD
Clozapine—HRH1—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	9.62e-06	0.000106	CbGpPWpGaD
Clozapine—CHRM1—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	9.59e-06	0.000106	CbGpPWpGaD
Clozapine—ADRA1B—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	9.57e-06	0.000106	CbGpPWpGaD
Clozapine—CHRM3—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	9.55e-06	0.000106	CbGpPWpGaD
Clozapine—ADRA2C—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	9.51e-06	0.000105	CbGpPWpGaD
Clozapine—DRD2—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	9.5e-06	0.000105	CbGpPWpGaD
Clozapine—HTR2A—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	9.49e-06	0.000105	CbGpPWpGaD
Clozapine—HRH1—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	9.47e-06	0.000105	CbGpPWpGaD
Clozapine—CYP1B1—Metabolism—ALB—acquired immunodeficiency syndrome	9.46e-06	0.000105	CbGpPWpGaD
Clozapine—CHRM2—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	9.46e-06	0.000105	CbGpPWpGaD
Clozapine—CHRM1—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	9.44e-06	0.000104	CbGpPWpGaD
Clozapine—ADRA1A—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	9.44e-06	0.000104	CbGpPWpGaD
Clozapine—CHRM3—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	9.41e-06	0.000104	CbGpPWpGaD
Clozapine—ADRA1B—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	9.36e-06	0.000103	CbGpPWpGaD
Clozapine—HTR2A—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	9.35e-06	0.000103	CbGpPWpGaD
Clozapine—HRH1—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	9.33e-06	0.000103	CbGpPWpGaD
Clozapine—CHRM2—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	9.32e-06	0.000103	CbGpPWpGaD
Clozapine—CHRM1—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	9.3e-06	0.000103	CbGpPWpGaD
Clozapine—ADRA1A—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	9.29e-06	0.000103	CbGpPWpGaD
Clozapine—CHRM3—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	9.27e-06	0.000102	CbGpPWpGaD
Clozapine—CHRM2—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	9.18e-06	0.000101	CbGpPWpGaD
Clozapine—ADRA1A—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	9.16e-06	0.000101	CbGpPWpGaD
Clozapine—HRH3—Signaling Pathways—IL6—acquired immunodeficiency syndrome	8.91e-06	9.84e-05	CbGpPWpGaD
Clozapine—DRD2—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	8.82e-06	9.75e-05	CbGpPWpGaD
Clozapine—ADRA2A—Signaling Pathways—CCL5—acquired immunodeficiency syndrome	8.77e-06	9.69e-05	CbGpPWpGaD
Clozapine—HTR2A—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	8.68e-06	9.59e-05	CbGpPWpGaD
Clozapine—HRH1—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	8.66e-06	9.57e-05	CbGpPWpGaD
Clozapine—ADRA2A—Signaling Pathways—CSF2—acquired immunodeficiency syndrome	8.64e-06	9.54e-05	CbGpPWpGaD
Clozapine—CHRM1—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	8.64e-06	9.54e-05	CbGpPWpGaD
Clozapine—DRD2—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	8.63e-06	9.54e-05	CbGpPWpGaD
Clozapine—CHRM3—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	8.61e-06	9.51e-05	CbGpPWpGaD
Clozapine—CHRM2—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	8.52e-06	9.42e-05	CbGpPWpGaD
Clozapine—ADRA2A—GPCR downstream signaling—IL2—acquired immunodeficiency syndrome	8.51e-06	9.4e-05	CbGpPWpGaD
Clozapine—ADRA1A—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	8.5e-06	9.39e-05	CbGpPWpGaD
Clozapine—HTR2A—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	8.49e-06	9.38e-05	CbGpPWpGaD
Clozapine—HRH1—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	8.47e-06	9.36e-05	CbGpPWpGaD
Clozapine—CHRM1—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	8.45e-06	9.33e-05	CbGpPWpGaD
Clozapine—CHRM3—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	8.42e-06	9.3e-05	CbGpPWpGaD
Clozapine—CYP1A2—Metabolism of lipids and lipoproteins—ALB—acquired immunodeficiency syndrome	8.34e-06	9.22e-05	CbGpPWpGaD
Clozapine—CHRM2—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	8.34e-06	9.21e-05	CbGpPWpGaD
Clozapine—ADRA1A—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	8.31e-06	9.19e-05	CbGpPWpGaD
Clozapine—ADRA2C—Metabolism—ALB—acquired immunodeficiency syndrome	8.29e-06	9.16e-05	CbGpPWpGaD
Clozapine—ADRA2A—Signaling Pathways—CCR5—acquired immunodeficiency syndrome	7.9e-06	8.73e-05	CbGpPWpGaD
Clozapine—HTR6—Signaling Pathways—IL2—acquired immunodeficiency syndrome	7.84e-06	8.67e-05	CbGpPWpGaD
Clozapine—HTR7—Signaling Pathways—IL2—acquired immunodeficiency syndrome	7.84e-06	8.66e-05	CbGpPWpGaD
Clozapine—CYP2A6—Metabolism—ALB—acquired immunodeficiency syndrome	7.82e-06	8.64e-05	CbGpPWpGaD
Clozapine—HTR6—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	7.81e-06	8.63e-05	CbGpPWpGaD
Clozapine—HTR7—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	7.8e-06	8.62e-05	CbGpPWpGaD
Clozapine—HTR1D—Signaling Pathways—IL2—acquired immunodeficiency syndrome	7.78e-06	8.6e-05	CbGpPWpGaD
Clozapine—HRH4—Signaling Pathways—IL6—acquired immunodeficiency syndrome	7.75e-06	8.57e-05	CbGpPWpGaD
Clozapine—HTR1D—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	7.75e-06	8.56e-05	CbGpPWpGaD
Clozapine—ADRA2A—Signaling by GPCR—IL2—acquired immunodeficiency syndrome	7.73e-06	8.54e-05	CbGpPWpGaD
Clozapine—HTR1B—Signaling Pathways—IL2—acquired immunodeficiency syndrome	7.62e-06	8.42e-05	CbGpPWpGaD
Clozapine—HTR1B—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	7.58e-06	8.38e-05	CbGpPWpGaD
Clozapine—DRD4—Signaling Pathways—IL2—acquired immunodeficiency syndrome	7.5e-06	8.29e-05	CbGpPWpGaD
Clozapine—DRD4—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	7.46e-06	8.25e-05	CbGpPWpGaD
Clozapine—CHRM4—Signaling Pathways—IL2—acquired immunodeficiency syndrome	7.4e-06	8.18e-05	CbGpPWpGaD
Clozapine—CHRM4—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	7.36e-06	8.14e-05	CbGpPWpGaD
Clozapine—CHRM3—Metabolism—ALB—acquired immunodeficiency syndrome	7.34e-06	8.11e-05	CbGpPWpGaD
Clozapine—CHRM5—Signaling Pathways—IL2—acquired immunodeficiency syndrome	7.09e-06	7.83e-05	CbGpPWpGaD
Clozapine—CHRM5—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	7.05e-06	7.79e-05	CbGpPWpGaD
Clozapine—DRD1—Signaling Pathways—IL2—acquired immunodeficiency syndrome	6.75e-06	7.46e-05	CbGpPWpGaD
Clozapine—HTR1E—Signaling Pathways—IL6—acquired immunodeficiency syndrome	6.75e-06	7.46e-05	CbGpPWpGaD
Clozapine—ADRA2A—Metabolism—ALB—acquired immunodeficiency syndrome	6.73e-06	7.44e-05	CbGpPWpGaD
Clozapine—DRD1—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	6.72e-06	7.42e-05	CbGpPWpGaD
Clozapine—DRD3—Signaling Pathways—IL2—acquired immunodeficiency syndrome	6.66e-06	7.36e-05	CbGpPWpGaD
Clozapine—DRD3—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	6.63e-06	7.33e-05	CbGpPWpGaD
Clozapine—CYP2E1—Metabolism—ALB—acquired immunodeficiency syndrome	6.18e-06	6.83e-05	CbGpPWpGaD
Clozapine—ADRA2B—Signaling Pathways—IL2—acquired immunodeficiency syndrome	6.02e-06	6.65e-05	CbGpPWpGaD
Clozapine—ADRA2B—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	5.99e-06	6.61e-05	CbGpPWpGaD
Clozapine—CYP1A1—Metabolism—ALB—acquired immunodeficiency syndrome	5.83e-06	6.44e-05	CbGpPWpGaD
Clozapine—HTR1A—Signaling Pathways—IL2—acquired immunodeficiency syndrome	5.81e-06	6.42e-05	CbGpPWpGaD
Clozapine—HTR1A—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	5.78e-06	6.38e-05	CbGpPWpGaD
Clozapine—HTR2C—Signaling Pathways—IL2—acquired immunodeficiency syndrome	5.78e-06	6.38e-05	CbGpPWpGaD
Clozapine—HTR2C—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	5.75e-06	6.35e-05	CbGpPWpGaD
Clozapine—ADRA2C—Signaling Pathways—IL2—acquired immunodeficiency syndrome	5.62e-06	6.21e-05	CbGpPWpGaD
Clozapine—ADRA2C—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	5.59e-06	6.18e-05	CbGpPWpGaD
Clozapine—ADRA1B—Signaling Pathways—IL2—acquired immunodeficiency syndrome	5.53e-06	6.11e-05	CbGpPWpGaD
Clozapine—ADRA1B—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	5.5e-06	6.08e-05	CbGpPWpGaD
Clozapine—CYP2C8—Metabolism—ALB—acquired immunodeficiency syndrome	5.34e-06	5.9e-05	CbGpPWpGaD
Clozapine—DRD2—Signaling Pathways—IL2—acquired immunodeficiency syndrome	5.1e-06	5.63e-05	CbGpPWpGaD
Clozapine—DRD2—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	5.07e-06	5.61e-05	CbGpPWpGaD
Clozapine—HTR2A—Signaling Pathways—IL2—acquired immunodeficiency syndrome	5.02e-06	5.54e-05	CbGpPWpGaD
Clozapine—HRH1—Signaling Pathways—IL2—acquired immunodeficiency syndrome	5.01e-06	5.53e-05	CbGpPWpGaD
Clozapine—HTR2A—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	4.99e-06	5.52e-05	CbGpPWpGaD
Clozapine—CHRM1—Signaling Pathways—IL2—acquired immunodeficiency syndrome	4.99e-06	5.51e-05	CbGpPWpGaD
Clozapine—HRH1—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	4.98e-06	5.5e-05	CbGpPWpGaD
Clozapine—CHRM3—Signaling Pathways—IL2—acquired immunodeficiency syndrome	4.97e-06	5.5e-05	CbGpPWpGaD
Clozapine—CHRM1—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	4.96e-06	5.49e-05	CbGpPWpGaD
Clozapine—CHRM3—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	4.95e-06	5.47e-05	CbGpPWpGaD
Clozapine—CHRM2—Signaling Pathways—IL2—acquired immunodeficiency syndrome	4.93e-06	5.44e-05	CbGpPWpGaD
Clozapine—ADRA1A—Signaling Pathways—IL2—acquired immunodeficiency syndrome	4.91e-06	5.43e-05	CbGpPWpGaD
Clozapine—CHRM2—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	4.9e-06	5.42e-05	CbGpPWpGaD
Clozapine—ADRA1A—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	4.89e-06	5.4e-05	CbGpPWpGaD
Clozapine—CYP2C19—Metabolism—ALB—acquired immunodeficiency syndrome	4.77e-06	5.27e-05	CbGpPWpGaD
Clozapine—ABCB1—Metabolism—ALB—acquired immunodeficiency syndrome	4.65e-06	5.14e-05	CbGpPWpGaD
Clozapine—HTR6—Signaling Pathways—IL6—acquired immunodeficiency syndrome	4.61e-06	5.1e-05	CbGpPWpGaD
Clozapine—HTR7—Signaling Pathways—IL6—acquired immunodeficiency syndrome	4.61e-06	5.09e-05	CbGpPWpGaD
Clozapine—HTR1D—Signaling Pathways—IL6—acquired immunodeficiency syndrome	4.58e-06	5.06e-05	CbGpPWpGaD
Clozapine—ADRA2A—Signaling Pathways—IL2—acquired immunodeficiency syndrome	4.56e-06	5.04e-05	CbGpPWpGaD
Clozapine—ADRA2A—Signaling by GPCR—IL6—acquired immunodeficiency syndrome	4.54e-06	5.02e-05	CbGpPWpGaD
Clozapine—HTR1B—Signaling Pathways—IL6—acquired immunodeficiency syndrome	4.48e-06	4.95e-05	CbGpPWpGaD
Clozapine—DRD4—Signaling Pathways—IL6—acquired immunodeficiency syndrome	4.41e-06	4.87e-05	CbGpPWpGaD
Clozapine—CYP2D6—Metabolism—ALB—acquired immunodeficiency syndrome	4.39e-06	4.85e-05	CbGpPWpGaD
Clozapine—CHRM4—Signaling Pathways—IL6—acquired immunodeficiency syndrome	4.35e-06	4.81e-05	CbGpPWpGaD
Clozapine—CYP2C9—Metabolism—ALB—acquired immunodeficiency syndrome	4.35e-06	4.81e-05	CbGpPWpGaD
Clozapine—CHRM5—Signaling Pathways—IL6—acquired immunodeficiency syndrome	4.17e-06	4.6e-05	CbGpPWpGaD
Clozapine—DRD1—Signaling Pathways—IL6—acquired immunodeficiency syndrome	3.97e-06	4.39e-05	CbGpPWpGaD
Clozapine—DRD3—Signaling Pathways—IL6—acquired immunodeficiency syndrome	3.92e-06	4.33e-05	CbGpPWpGaD
Clozapine—CYP1A2—Metabolism—ALB—acquired immunodeficiency syndrome	3.72e-06	4.11e-05	CbGpPWpGaD
Clozapine—ADRA2B—Signaling Pathways—IL6—acquired immunodeficiency syndrome	3.54e-06	3.91e-05	CbGpPWpGaD
Clozapine—HTR1A—Signaling Pathways—IL6—acquired immunodeficiency syndrome	3.41e-06	3.77e-05	CbGpPWpGaD
Clozapine—HTR2C—Signaling Pathways—IL6—acquired immunodeficiency syndrome	3.4e-06	3.75e-05	CbGpPWpGaD
Clozapine—ADRA2C—Signaling Pathways—IL6—acquired immunodeficiency syndrome	3.3e-06	3.65e-05	CbGpPWpGaD
Clozapine—ADRA1B—Signaling Pathways—IL6—acquired immunodeficiency syndrome	3.25e-06	3.59e-05	CbGpPWpGaD
Clozapine—DRD2—Signaling Pathways—IL6—acquired immunodeficiency syndrome	3e-06	3.31e-05	CbGpPWpGaD
Clozapine—HTR2A—Signaling Pathways—IL6—acquired immunodeficiency syndrome	2.95e-06	3.26e-05	CbGpPWpGaD
Clozapine—HRH1—Signaling Pathways—IL6—acquired immunodeficiency syndrome	2.94e-06	3.25e-05	CbGpPWpGaD
Clozapine—CHRM1—Signaling Pathways—IL6—acquired immunodeficiency syndrome	2.93e-06	3.24e-05	CbGpPWpGaD
Clozapine—CHRM3—Signaling Pathways—IL6—acquired immunodeficiency syndrome	2.92e-06	3.23e-05	CbGpPWpGaD
Clozapine—CHRM2—Signaling Pathways—IL6—acquired immunodeficiency syndrome	2.9e-06	3.2e-05	CbGpPWpGaD
Clozapine—ADRA1A—Signaling Pathways—IL6—acquired immunodeficiency syndrome	2.89e-06	3.19e-05	CbGpPWpGaD
Clozapine—CYP3A4—Metabolism—ALB—acquired immunodeficiency syndrome	2.87e-06	3.17e-05	CbGpPWpGaD
Clozapine—ADRA2A—Signaling Pathways—IL6—acquired immunodeficiency syndrome	2.68e-06	2.96e-05	CbGpPWpGaD
